In a landmark deal that will transform diabetes care in India, Emcure Pharmaceuticals has entered an exclusive partnership with Sanofi India to sell and distribute some of Sanofi's most established oral anti-diabetic (OAD) products in the country...
An appeal has been made to the Prime Minister by Sumanata Kumar Tiwari, the joint director-cum-drug controller of Jharkhand, for a significant overhaul of the current regulatory framework to combat the escalating menace of counterfeit medicines
.png)
PharmaJet has signed a strategic Memorandum of Understanding with Egypt’s Unified Procurement Authority (UPA) and leading pharmaceutical company EVA Pharma to enable introduction of needle-free vaccine delivery as part of their routine...
India’s pharmaceutical sector is focused on a major goal of increasing exports to USD 1 trillion, and biosimilars are emerging as the cornerstone of this growth. Currently valued at USD 50–55 billion, pharmaceutical exports from India are expected...
In a bold strategic shift, Wockhardt has divested its U.S. generics business to focus on high-value, innovative therapies, including novel antibiotics and biologics. The company announced the voluntary liquidation of Wockhardt USA LLC and Morton...
In a landmark move for India's biopharma industry, Ichnos Glenmark Innovation (IGI)—a partnership between Glenmark Pharmaceuticals and Ichnos Sciences—has signed a USD 2 billion licensing deal with AbbVie, a leading US pharmaceutical company...
Sun Pharmaceutical Industries is working toward a complete regulatory resolution for three of its manufacturing facilities that are being reviewed by the US Food and Drug Administration (USFDA). Sun Pharmaceutical has completed way of corrective...
In a remarkable move, Nectar Lifesciences announced the sale of its core active pharmaceutical ingredients (API), formulations and menthol business to Ceph Lifesciences Pvt Ltd, a total consideration of Rs 1,290 crore. The transaction includes a...
In an exclusive interaction with India Pharma Outlook, Nitin Stephen Abel, Senior Director, Terumo Interventional Systems, Terumo India, discusses how India’s shift toward outpatient surgeries is driving medical device manufacturers to reengineer min
According to Lok Sabha Speaker Om Birla, India is quickly establishing itself as a global hub for pharmaceuticals and medical research. In New Delhi, Birla said this at the 7th International Conference of the Innovative Physicians Forum...
.jpg)
, CDSCO.jpg)